Concepedia

Yingna Cai

YC

8

Publications

444

Citations

8

H-Index

1993

Active since

Affiliations

Abbott Fund(Current)

The University of Texas MD Anderson Cancer Center

Abbott (United Kingdom)

Yingna Cai is an author at Abbott Fund specializing in medicine, medicinal chemistry, and drug discovery.

Top concepts

Publications per year

1993–2006

8

Publications

8

In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone

Angela M. Nilius, Linus L. Shen, Dena M. Hensey-Rudloff et al. · Antimicrobial Agents and Chemotherapy · 2003 · 113 citations · Full text

The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 Study

Kenneth R. Hande, A. Hagey, Jordan Berlin et al. · Clinical Cancer Research · 2006 · 81 citations

Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufin O-dealkylase by naturally occurring coumarins

Yingna Cai, Daniel Bennett, Raghunathan V. Nair et al. · Chemical Research in Toxicology · 1993 · 54 citations

Mechanism-Based Inactivation of Hepatic Ethoxyresorufin O-Dealkylation Activity by Naturally Occurring Coumarins

Yingna Cai, Wanda Baer‐Dubowska, Mike J. Ashwood-Smith et al. · Chemical Research in Toxicology · 1996 · 51 citations

Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases.

Yingna Cai, Michael H. Wu, Meng Xu‐Welliver et al. · PubMed · 2000 · 48 citations

, , +16

Rows per page

1–5 of 8